• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CDISC Releases Data Management Guidance for COVID-19 Trials

CDISC Releases Data Management Guidance for COVID-19 Trials

April 27, 2020

The Clinical Data Interchange Standards Consortium (CDISC) has released an annotated case report form (CRF) template to help sites apply CDISC standards to data anomalies resulting from trial adjustments during the COVID-19 pandemic as part of its new user guide.

The Novel Coronavirus Acute Respiratory Infection Clinical Characterization Data Tool was developed by the World Health Organization and the International Severe Acute Respiratory and Emerging Infection Consortium.

The guide’s recommendations for ongoing studies disrupted by COVID-19 include methods for listing COVID-19-related impacts as part of the clinical study report as well as how to handle protocol deviations, missed visits and assessments, changes to adverse event data collection, and patient transfers to another site due to site closure.

The CDISC guidance also offers data structuring recommendations for trials of COVID-19 vaccines and treatments that include patients with pre-existing medical conditions. The guidance provides recommendations on how to record whether healthcare workers wore personal protective equipment and/or if they came into contact with infected people or facilities that contained the coronavirus. Recommendations on how to record onset of disease, signs and symptoms, laboratory test results, and hospitalizations are also provided.

A CDISC task force of industry researchers, data standards experts and academic researchers formed in March developed the user guide in just under a month. “Because so much relies on our standards, CDISC teams are very meticulous, and we take our time to build these standards carefully,” says David R. Bobbitt, CEO of CDISC.

Find the full CDISC User Guide here: https://bit.ly/2Y5mt4m.

COVID-19
  • Related Directories

    Veklury (remdesivir)

    Comirnaty (COVID-19 Vaccine, mRNA)

    Spikevax, COVID-19 Vaccine (mRNA-1273)

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing